NCT06978933
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China
Clinical trial condition
HCC - Hepatocellular Carcinoma
Explore clinical trials studying HCC - Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
80 public trials
38 recruiting studies
HCC - Hepatocellular Carcinoma trial results
NCT06883539
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +31 more
- Locations
-
- China Medical University Hospital Taichung, Taiwan
- National Cheng Kung University Hospital Tainan, Taiwan
Recruiting
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
NCT06870942
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
Recruiting
Sarcopenia and Systemic Therapy in HCC
NCT06805552
- Conditions
- Adenocarcinoma, Atrophy, Carcinoma, +18 more
- Locations
-
- IRCCS AOUBO Policlinico di S.Orsola Bologna, Italy
NCT06777017
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
NCT06774690
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
Recruiting
Mts105 for Advanced Hepatocellular Carcinoma
NCT06689540
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Peking University Cancer Hospital Beijing, China
Recruiting
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
NCT04371042
- Conditions
- Adenocarcinoma, Body Weight, Carcinoma, +33 more
- Locations
-
- Catholic University of Rome, Fondazione Policlinico Gemelli IRCCS Roma, Rome/lazio/italy, Italy
Not yet recruiting
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes
NCT07557914
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
- Locations
-
- The First Hospital of China Medical University Shenyang, Liaoning, China
Not yet recruiting
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
NCT07691645
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China